Chronic disease impacts millions of individuals and families worldwide and will increase as a product of population aging, improvements in public health and advancements in medical science.
The purpose of the Bridgepoint Study was to understand the needs and experiences of individuals with complex chronic disease and to use this information to improve data quality, services and policies, both within and outside the hospital.
This is the first substantial study of complex chronic disease in rehabilitation and tertiary care and provides an inclusive snapshot, from the patient perspective, on what it is like to have multiple health problems.
- To answer the main research question, "What are the characteristics and care needs of individuals at Bridgepoint Health?"
- To analyze the characteristics of the Bridgepoint patient population using hospital assessment data and semi-structured interviews with our patients.
- To examine Bridgepoint patient characteristics as they relate to mental health, social health, physical health, socio-demographics, and health experiences and outcomes.
- To improve the understanding of complex chronic disease.
- To present our findings to local, national and international audiences.
- Complex care requires a different model of care than the acute model, characterized by providers who are given the capacity (i.e., the tools) to respond to changing, fluctuating health problems of patients, and meet the physical, social and mental health needs of those they serve.
- Many patients with complex chronic disease experience mental health challenges including depressive symptomology, stress and anxiety.
- Transitions are problematic: Greater support and expectation management is required at both admission and discharge. Appropriate linkages to other points of care is required at discharge and should be better established.
- This patient population spans all ages, is extremely diverse, and is characterized by a mix of health problems, symptoms and illness histories.
- *Dr. Kerry Kuluski, Research Scientist, Bridgepoint Collaboratory for Research and Innovation
- Dr. Renée Lyons, TD Scientific Director and Bridgepoint Chair in Complex Chronic Disease Research, Bridgepoint Collaboratory for Research and Innovation
- Dr. Celeste Alvaro, Research Scientist, Bridgepoint Collaboratory for Research and Innovation
- Dr. Bob Bernstein, Lead Physician, Bridgepoint Family Health Team
- Alexis Schaink, Epidemiologist, Bridgepoint Collaboratory for Research and Innovation
*The Lead Scientist, Dr. Kerry Kuluski is generously supported by Great-West Life, London Life, Canada Life New Scientist Fund.
Presentation from the Canadian Association for Health Services and Policy Research (CAHSPR) Conference held in Montreal Quebec, May 29-31, 2012. https://cahspr.ca/sites/default/files/imce/B6.2%20-%20Kuluski.pdfPresentation abstract from the St. Mary's Hospital Research Speaker Series in Montreal, QC, April 12, 2012.